CHELMSFORD, Mass., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, today reported financial results for the fourth quarter and full year ended September 30, 2014.
Fiscal Fourth Quarter of 2014 Financial and Operational Highlights:
- Revenue was $122.5 million, an increase of 4% compared to the prior quarter;
- GAAP Net Income was $0.2 million with diluted EPS of $0.00;
- Non-GAAP Net Income was $4.7 million with diluted EPS of $0.07;
- Life Science Systems Revenue increased 9% on a sequential basis to $20.0 million;
- Operating cash flow was $13.4 million.
Fiscal Full Year 2014 Financial and Operational Highlights:
- Revenue was $483 million, an increase of 14% compared to the prior fiscal year;
- GAAP net income was $31 million with diluted EPS of $0.46;
- Non-GAAP net income was $17 million with diluted EPS of $0.25;
- Life Science Systems revenue was $63 million, 46% higher than 2013;
- Operating cash flow was $54 million;
- Total Cash, Cash Equivalents and Marketable Securities, as of September 30, was $245 million or $3.63 per Diluted Share with no bank debt.
| Summary of GAAP and Non-GAAP Earnings | |||
| Quarter Ended | |||
| September 30, | June 30, | September 30, | |
| Dollars in thousands, except per share data | 2014 | 2014 | 2013 |
| GAAP net income attributable to Brooks Automation, Inc. | $ 248 | $ 24,476 | $ 6,015 |
| GAAP diluted earnings per share | $ 0.00 | $ 0.36 | $ 0.09 |
| Non-GAAP net income attributable to Brooks Automation, Inc. | $ 4,726 | $ 3,602 | $ 4,702 |
| Non-GAAP diluted earnings per share | $ 0.07 | $ 0.05 | $ 0.07 |
A reconciliation of non-GAAP measures to the most nearly comparable GAAP measure follows the consolidated balance sheets, statements of operations and statements of cash flows included in this release.
Management Comments
"The fourth quarter was a solid finish to a transformative year for Brooks. We achieved sequential growth across all business segments during the fourth quarter, as well as year-over-year growth across all segments for the fiscal year. Growth came with higher margins as we continued to focus on higher value-added products and solutions," stated Dr. Steve Schwartz, Chief Executive Officer of Brooks. "2014 was a pivotal year for Brooks as we transformed our capabilities in multiple areas. Organic development of our first Brooks biostore systems platform drove Life Science Systems growth of 46%. The acquisition of our new Contamination Control Solutions business has contributed to 12% growth in the Product Solutions segment on a continuing operations basis and placed us into another growth space with the semiconductor customers. Both of these initiatives, combined with continuous cost reduction initiatives and the recent acquisition of FluidX, have positioned us for continued profitable growth in 2015 and beyond."
GAAP Summary
Revenue grew 4% sequentially to $122.5 million in the fourth quarter of fiscal 2014. Revenue growth was driven by the Life Science Systems segment and the expansion of our recent acquisition of DMS in the Product Solutions segment. Net income of $0.2 million improved $3.0 million compared to the continuing operations of the third quarter. Revenue grew $5.2 million compared to the third quarter, while the gross margin increased $0.7 million net of the step-up charges for purchase accounting treatment of our new Contamination Control Solutions business. In total, pre-tax income improved $5.0 million compared to the prior quarter primarily driven by reduced operating expenses. The primary driver of sequential pre-tax income improvement was a $4.6 million reduction of operating expense. Within operating expenses, restructuring charges declined $1.5 million and the prior quarter included a $2.6 million impairment of a note receivable.
In the full year fiscal 2014 period, revenue was $483 million, 14% higher than 2013 on continuing operations basis. Net income from continuing operations was $1.4 million, an improvement of $8.6 million compared to 2013. The diluted EPS from continuing operations was $0.02, an improvement of $0.13 compared to 2013 continuing operations. In addition, the business had $30 million of income from discontinued operations related to the divestiture of our Granville-Phillips business. The diluted EPS from discontinued operations was $0.44, providing a total of $0.46 diluted EPS for the 2014 fiscal year.
Net income of $31 million improved $34 million year-over-year. $25 million of the improved income was from discontinued operations related to the sale of the Granville-Phillips business. $8.6 million of the income improvement was from continuing operations
There are a number of special charges and one-time items reflected in both fiscal 2014 and fiscal 2013. The impact on earnings of these items and the amortization of intangibles is set out in the unaudited table included with this release.
Results of Q4, Fiscal 2014 (Non-GAAP Discussion)
Non-GAAP net income was $4.7 million in the fourth quarter, resulting in non-GAAP earnings per share of $0.07 and a sequential quarterly improvement of $1.1 million. The revenue of $122.5 million grew 4% compared to the third quarter, and was supported by sequential growth in all three segments. The primary growth was seen in Life Science Systems at 9% and in Product Solutions at 5%, compared to the third quarter.
Profit improvement was primarily driven by the higher revenue, although adjusted gross margins and operating expenses also showed improvement over the prior quarter. Adjusted gross margins, which exclude amortization and purchase accounting impacts, were 36.3% in the quarter, a 20 basis point improvement. The primary driver of margin improvement came from Life Science Systems which achieved 40.2%, a 174 basis point improvement compared to the third quarter. Non-GAAP operating expenses of $38.7 million also showed a modest 1% improvement compared to the third quarter.
Total order bookings in the fourth quarter were $130.8 million compared to $105.3 million in the third quarter. The Life Science Systems business had $12.6 million of new orders in the fourth quarter and finished with $44 million of total backlog with $34 million in 12-month backlog. This excludes backlog from our new consumables business, FluidX, which was acquired after the end of the quarter on October 1, 2014.
Adjusted EBITDA in the quarter was $10.9 million compared to $9.2 million in the third quarter. Cash flow from operations for the fourth quarter was $13.4 million. The Company's cash, cash equivalents, and marketable securities increased $1.7 million in the fourth quarter to close at $245.5 million. On October 1, 2014, we acquired FluidX, a provider of biosample consumable tubes and bench-top equipment, for approximately $16 million which was a use of cash subsequent to our year end.
Fiscal Year 2014 Results (Non-GAAP Discussion)
Revenue for the full fiscal year ended September 30, 2014 was $483 million, an increase of 14% compared to revenue of $422 million in 2013. The year-over-year growth was driven by growth in Life Science Systems of 46%, Product Solutions of 12%, and Global Services of 6%. Non-GAAP net income increased to $17.2 million or $0.25 per diluted share in fiscal 2014 from $7.7 million or $0.12 per diluted share in 2013. The increase in non-GAAP net income is primarily attributable to the revenue growth and 274 basis points improvement in adjusted gross profit margins.
During fiscal year 2014, we invested approximately $36 million of cash for acquisitions, received $85 million of cash for the divestiture of our Granville-Phillips business, and returned $23 million to shareholders in the form of dividends. Operating cash flow for the fiscal year of $54 million combined with our total financing and investing activity, resulted in the year-end cash position of $245 million at September 30, 2014. As mentioned above, on October 1, 2014, we paid approximately $16 million cash for the acquisition of FluidX, which was a use of cash subsequent to our year end.
Quarterly Cash Dividend
As previously announced, the Board of Directors has declared a dividend of $0.10 per share payable on December 26, 2014 to stockholders of record on December 5, 2014. Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the Company's Board of Directors.
Guidance for First Fiscal Quarter of Fiscal 2015
The Company announced revenue and earnings guidance for the first quarter of fiscal 2015. Revenue is expected to be in the range of $125 million to $130 million. Non-GAAP diluted earnings per share excluding special charges and intangibles amortization expense is expected to be in the range of $0.05 to $0.07.
Conference Call
Brooks management will webcast its fourth quarter earnings conference call today at 4:30 p.m. Eastern Time to discuss the fiscal fourth quarter and year-end results and business highlights. During the call, Company management will respond to questions concerning, but not limited to, the Company's financial performance, business conditions and industry outlook. Management's responses could contain information that has not been previously disclosed.
The call will be broadcast live over the Internet and, together with presentation materials referenced on the call, will be hosted at the Investor Relations section of Brooks' website at www.brooks.com, and will be archived online on this website for convenient on-demand replay. In addition, you may call 800-768-2950 (US & Canada only) or 1-212-231-2906 to listen to the live webcast.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. Brooks' technologies, engineering competencies and global service capabilities provide customers speed to market and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market and, through product development initiatives and strategic business acquisitions, has expanded offerings to meet the needs of customers in the life sciences industry, analytical & research markets and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia.
For more information, visit www.brooks.com.
"Safe Harbor Statement" under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include statements regarding our revenue and operating margin expectations, our ability to develop further our business in new and adjacent markets, and our ability to achieve financial success in the future. Factors that could cause results to differ from our expectations include the following: volatility of the industries the Company serves, particularly the semiconductor industry; our possible inability to meet demand for our products due to difficulties in obtaining components and materials from our suppliers in required quantities and of required quality; the inability of customers to make payments to us when due; the timing and effectiveness of cost reduction and cost control measures; price competition; disputes concerning intellectual property; continuing uncertainties in global political and economic conditions, and other factors and other risks that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.
| BROOKS AUTOMATION, INC. | ||
| CONSOLIDATED BALANCE SHEETS | ||
| (unaudited) | ||
| (In thousands, except share and per share data) | ||
| September 30, | September 30, | |
| 2014 | 2013 | |
| (In thousands, except share and per share data) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $ 94,114 | $ 82,971 |
| Restricted cash | — | 177 |
| Marketable securities | 68,130 | 45,900 |
| Accounts receivable, net | 80,106 | 77,483 |
| Inventories | 93,567 | 94,411 |
| Deferred tax assets | 19,009 | 16,839 |
| Assets held for sale | — | 27,778 |
| Prepaid expenses and other current assets | 19,387 | 9,030 |
| Total current assets | 374,313 | 354,589 |
| Property, plant and equipment, net | 50,183 | 47,506 |
| Long-term marketable securities | 83,212 | 44,491 |
| Long-term deferred tax assets | 67,563 | 99,146 |
| Goodwill | 109,501 | 97,924 |
| Intangible assets, net | 59,550 | 60,088 |
| Equity method investments | 28,944 | 25,687 |
| Other assets | 4,772 | 7,332 |
| Total assets | $ 778,038 | $ 736,763 |
| Liabilities and equity | ||
| Current liabilities | ||
| Accounts payable | $ 33,740 | $ 35,392 |
| Capital lease obligation | 881 | — |
| Deferred revenue | 26,279 | 19,610 |
| Accrued warranty and retrofit costs | 6,499 | 7,260 |
| Accrued compensation and benefits | 21,663 | 14,225 |
| Accrued restructuring costs | 3,475 | 1,412 |
| Accrued income taxes payable | 1,808 | 1,058 |
| Deferred tax liabilities | 808 | 19 |
| Liabilities held for sale | — | 132 |
| Accrued expenses and other current liabilities | 18,688 | 13,453 |
| Total current liabilities | 113,841 | 92,561 |
| Long-term capital lease obligation | 7,417 | — |
| Long-term tax reserves | 5,708 | 6,115 |
| Long-term deferred tax liabilities | 2,567 | 921 |
| Long-term pension liability | 1,774 | 815 |
| Other long-term liabilities | 3,842 | 3,695 |
| Total liabilities | 135,149 | 104,107 |
| Commitments and contingencies | ||
| Equity | ||
| Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding | — | — |
| Common stock, $0.01 par value, 125,000,000 shares authorized, 80,375,777 shares issued and 66,913,908 shares outstanding at September 30, 2014, 80,039,104 shares issued and 66,577,235 shares outstanding at September 30, 2013 | 804 | 800 |
| Additional paid-in capital | 1,834,619 | 1,825,499 |
| Accumulated other comprehensive income | 15,687 | 22,604 |
| Treasury stock at cost, 13,461,869 shares | (200,956) | (200,956) |
| Accumulated deficit | (1,007,265) | (1,015,991) |
| Total Brooks Automation, Inc. stockholders' equity | 642,889 | 631,956 |
| Noncontrolling interest in subsidiaries | — | 700 |
| Total equity | 642,889 | 632,656 |
| Total liabilities and equity | $ 778,038 | $ 736,763 |
| BROOKS AUTOMATION, INC. | ||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||
| (unaudited) | ||||
| (In thousands, except per share data) | ||||
| Three months ended | Year Ended | |||
| September 30, | September 30, | |||
| 2014 | 2013 | 2014 | 2013 | |
| Revenue | ||||
| Product | $ 98,145 | $ 86,771 | $ 387,032 | $ 335,011 |
| Services | 24,372 | 23,910 | 95,816 | 87,429 |
| Total revenue | 122,517 | 110,681 | 482,848 | 422,440 |
| Cost of revenue | ||||
| Product | 67,181 | 56,914 | 252,688 | 229,411 |
| Services | 13,934 | 16,899 | 62,823 | 60,722 |
| Total cost of revenue | 81,115 | 73,813 | 315,511 | 290,133 |
| Gross profit | 41,402 | 36,868 | 167,337 | 132,307 |
| Operating expenses | ||||
| Research and development | 14,111 | 12,578 | 52,649 | 46,209 |
| Selling, general and administrative | 26,286 | 25,204 | 111,098 | 96,516 |
| Restructuring and other charges | 1,648 | 379 | 6,289 | 6,380 |
| Total operating expenses | 42,045 | 38,161 | 170,036 | 149,105 |
| Operating income (loss) | (643) | (1,293) | (2,699) | (16,798) |
| Interest income | 265 | 237 | 950 | 1,032 |
| Interest expense | (101) | (1) | (202) | (2) |
| Other income (expense), net | (216) | 856 | 256 | 1,227 |
| Loss before income taxes and equity in earnings of equity method investments | (695) | (201) | (1,695) | (14,541) |
| Income tax provision (benefit) | (1,052) | 112 | (1,980) | (4,985) |
| Income (loss) before equity in earnings of equity method investments | 357 | (313) | 285 | (9,556) |
| Equity in earnings (losses) of equity method investments | (95) | 2,222 | 1,235 | 2,442 |
| Income (loss) from continuing operations | 262 | 1,909 | 1,520 | (7,114) |
| Income from discontinued operations, net of tax | — | 4,103 | 30,002 | 4,964 |
| Net income (loss) | 262 | 6,012 | 31,522 | (2,150) |
| Net income (loss) attributable to noncontrolling interests | (14) | 3 | (161) | (65) |
| Net income (loss) attributable to Brooks Automation, Inc. | $ 248 | $ 6,015 | $ 31,361 | $ (2,215) |
| Basic net income (loss) per share attributable to Brooks Automation, Inc. common stockholders: | ||||
| Income (loss) from continuing operations | $ — | $ 0.03 | $ 0.02 | $ (0.11) |
| Income from discontinued operations, net of tax | — | 0.06 | 0.45 | 0.08 |
| Basic net income (loss) per share attributable to Brooks Automation, Inc. | $ — | $ 0.09 | $ 0.47 | $ (0.03) |
| Diluted net income (loss) per share attributable to Brooks Automation, Inc. common stockholders: | ||||
| Income (loss) from continuing operations | $ — | $ 0.03 | $ 0.02 | $ (0.11) |
| Income from discontinued operations, net of tax | — | 0.06 | 0.44 | 0.08 |
| Diluted net income (loss) per share attributable to Brooks Automation, Inc. common stockholders | $ — | $ 0.09 | $ 0.46 | $ (0.03) |
| Dividend declared per share | $ 0.10 | $ 0.08 | $ 0.34 | $ 0.32 |
| Weighted-average shares used in computing earnings (loss) per share: | ||||
| Basic | 66,840 | 65,153 | 66,648 | 65,912 |
| Diluted | 67,925 | 66,902 | 67,644 | 65,912 |
| BROOKS AUTOMATION, INC. | ||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
| (unaudited) | ||
| (In thousands) | ||
| Year Ended September 30, | ||
| 2014 | 2013 | |
| Cash flows from operating activities | ||
| Net income (loss) | $ 31,522 | $ (2,150) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 23,459 | 24,155 |
| Impairment of intangible assets | 398 | 1,960 |
| Impairment of other assets | 2,621 | — |
| Stock-based compensation | 10,912 | 7,757 |
| Amortization of premium on marketable securities | 1,255 | 1,274 |
| Undistributed earnings of equity method investments | (1,235) | (2,442) |
| Deferred income tax benefit | (1,779) | (2,936) |
| Pension settlement | — | 87 |
| Gain on disposal of businesses | (27,444) | — |
| Loss (gain) on disposal of long-lived assets | 13 | (1,394) |
| Changes in operating assets and liabilities, net of acquisitions and disposals: | ||
| Accounts receivable | 12,098 | 6,422 |
| Inventories | 9,598 | 15,490 |
| Prepaid expenses and other current assets | (12,325) | 4,359 |
| Accounts payable | (11,924) | 3,123 |
| Deferred revenue | 5,900 | 8,971 |
| Accrued warranty and retrofit costs | (1,102) | (1,806) |
| Accrued compensation and benefits | 6,783 | (2,625) |
| Accrued restructuring costs | 2,161 | (972) |
| Accrued pension | 997 | (950) |
| Accrued expenses and other current liabilities | 1,873 | (3,934) |
| Net cash provided by operating activities | 53,781 | 54,389 |
| Cash flows from investing activities | ||
| Purchases of property, plant and equipment | (5,518) | (3,635) |
| Purchases of marketable securities | (174,287) | (91,740) |
| Sale/maturity of marketable securities | 112,085 | 145,023 |
| Proceeds from divestitures | 85,369 | — |
| Acquisitions, net of cash acquired | (35,625) | (68,331) |
| Decrease in restricted cash | 177 | 586 |
| Proceeds from the sale of property, plant and equipment | — | 14,082 |
| Payment of deferred leasing cost | — | (3,134) |
| Net cash used in investing activities | (17,799) | (7,149) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock, net of issuance costs | 1,838 | 1,851 |
| Repayment of capital lease obligations | (239) | — |
| Acquisition of noncontrolling interest | (3,189) | — |
| Common stock dividend paid | (22,875) | (21,328) |
| Net cash used in financing activities | (24,465) | (19,477) |
| Effects of exchange rate changes on cash and cash equivalents | (374) | 569 |
| Net increase in cash and cash equivalents | 11,143 | 28,332 |
| Cash and cash equivalents, beginning of year | 82,971 | 54,639 |
| Cash and cash equivalents, end of year | $ 94,114 | $ 82,971 |
| Supplemental disclosures: | ||
| Cash paid during the year for interest | $ 202 | $ 2 |
| Cash paid (refunded) during the year for income taxes, net | $ 1,084 | $ (762) |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Acquisition of buildings and land through capital lease | $ 8,537 | $ — |
Notes on Non-GAAP Financial Measures:
The information in this press release is for: internal managerial purposes; when publicly providing guidance on future results; and as a means to evaluate period-to-period comparisons. These financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and should not be relied upon to the exclusion of GAAP financial measures. Management believes these financial measures provide an additional way of viewing aspects of our operations, that, when viewed with our GAAP results and the accompanying reconciliations to the corresponding GAAP financial measures, provide a more complete understanding of our business. Management strongly encourages investors to review our financial statements and publicly-filed reports in their entirety and not rely on any single measure.
The press release includes financial measures which exclude the effects of special charges such as restructuring charges and acquisition related charges. Management believes these measures are useful to investors because it eliminates accounting charges that do not reflect Brooks' day-to-day operations. Tables reconciling GAAP to the non-GAAP measures are presented below.
| Quarter Ended | ||||||
| September 30, 2014 | June 30, 2014 | September 30, 2013 | ||||
| Dollars in thousands, except per share data |
$ |
per diluted share |
$ |
per diluted share |
$ |
per diluted share |
| Net income attributable to Brooks Automation, Inc. | $ 248 | $ 0.00 | $ 24,476 | $ 0.36 | $ 6,015 | $ 0.09 |
| Income from discontinued operations, net of tax | — | — | 27,263 | 0.40 | 4,103 | 0.06 |
| Net income (loss) attributable to continuing operations | 248 | 0.00 | (2,787) | (0.04) | 1,912 | 0.03 |
| Adjustments, net of tax: | ||||||
| Purchase accounting impact on inventory and contracts acquired | 1,300 | 0.02 | 99 | 0.00 | 87 | 0.00 |
| Amortization of intangible assets | 1,964 | 0.03 | 1,850 | 0.03 | 1,666 | 0.02 |
| Impairment of intangible assets | — | — | — | — | 1,274 | 0.02 |
| Impairment of note receivable | — | — | 1,704 | 0.03 | — | — |
| Restructuring charges | 1,151 | 0.02 | 2,126 | 0.03 | 287 | 0.00 |
| Inventory write-downs related to restructuring programs | — | — | 210 | 0.00 | — | — |
| Merger costs | 63 | 0.00 | 400 | 0.01 | 142 | 0.00 |
| Gain on sale of real estate | — | — | — | — | (666) | (0.01) |
| Adjusted net income attributable to Brooks Automation, Inc. | 4,726 | 0.07 | 3,602 | 0.05 | 4,702 | 0.07 |
| Stock-based compensation | 2,138 | 0.03 | 2,258 | 0.03 | 2,103 | 0.03 |
| Adjusted net income attributable to Brooks Automation, Inc. - excluding stock-based compensation | $ 6,864 | $ 0.10 | $ 5,860 | $ 0.09 | $ 6,805 | $ 0.10 |
| Twelve Months Ended | ||||
| September 30, 2014 | September 30, 2013 | |||
| Dollars in thousands, except per share data |
$ |
per diluted share |
$ |
per diluted share |
| Net income (loss) attributable to Brooks Automation, Inc. | $ 31,361 | $ 0.46 | $ (2,215) | $ (0.03) |
| Income from discontinued operations, net of tax | 30,002 | 0.44 | 4,964 | 0.08 |
| Net income (loss) attributable to continuing operations | 1,359 | 0.02 | (7,179) | (0.11) |
| Adjustments, net of tax: | ||||
| Purchase accounting impact on inventory and contracts acquired | 1,628 | 0.02 | 2,179 | 0.03 |
| Amortization of intangible assets | 7,111 | 0.11 | 6,782 | 0.10 |
| Impairment of intangible assets | 259 | 0.00 | 1,274 | 0.02 |
| Impairment of note receivable | 1,704 | 0.03 | — | — |
| Restructuring charges | 4,311 | 0.06 | 4,644 | 0.07 |
| Inventory write-downs related to restructuring programs | 210 | 0.00 | — | — |
| Merger costs | 584 | 0.01 | 646 | 0.01 |
| Gain on sale of real estate | — | — | (666) | (0.01) |
| Adjusted net income attributable to Brooks Automation, Inc. | 17,166 | 0.25 | 7,680 | 0.12 |
| Stock-based compensation | 10,914 | 0.16 | 7,608 | 0.12 |
| Adjusted net income attributable to Brooks Automation, Inc. - excluding stock-based compensation | $ 28,080 | $ 0.42 | $ 15,288 | $ 0.23 |
| Quarter Ended | ||||||
| September 30, 2014 | June 30, 2014 | September 30, 2013 | ||||
| Dollars in thousands | $ | % | $ | % | $ | % |
| Gross profit/gross margin percentage | $ 41,402 | 33.8% | $ 40,746 | 34.7% | $ 36,868 | 33.3% |
| Adjustments: | ||||||
| Amortization of intangible assets | 1,249 | 1.0% | 1,142 | 1.0% | 1,063 | 1.0% |
| Impairment of intangible assets | — | —% | — | —% | 1,910 | 1.7% |
| Purchase accounting impact on inventory and contracts acquired | 1,805 | 1.5% | 138 | 0.1% | 134 | 0.1% |
| Inventory write-downs related to restructuring programs | — | —% | 310 | 0.3% | — | —% |
| Adjusted gross profit/gross margin percentage | $ 44,456 | 36.3% | $ 42,336 | 36.1% | $ 39,975 | 36.1% |
| Twelve Months Ended | ||||
| September 30, 2014 | September 30, 2013 | |||
| Dollars in thousands | $ | % | $ | % |
| Gross profit/gross margin percentage | $ 167,337 | 34.7% | $ 132,307 | 31.3% |
| Adjustments: | ||||
| Amortization of intangible assets | 4,422 | 0.9% | 4,065 | 1.0% |
| Impairment of intangible assets | 398 | 0.1% | 1,910 | 0.5% |
| Purchase accounting impact on inventory and contracts acquired | 2,295 | 0.5% | 3,041 | 0.7% |
| Inventory write-downs related to restructuring programs | 310 | 0.1% | — | —% |
| Adjusted gross profit/gross margin percentage | $ 174,762 | 36.2% | $ 141,323 | 33.5% |
| Quarter Ended | Twelve Months Ended | ||||
| September 30, | June 30, | September 30, | September 30, | September 30, | |
| Dollars in thousands | 2014 | 2014 | 2013 | 2014 | 2013 |
| Net income (loss) attributable to Brooks Automation, Inc. | $ 248 | $ 24,476 | $ 6,015 | $ 31,361 | $ (2,215) |
| Adjustments: | |||||
| Less: Interest income | (265) | (181) | (237) | (950) | (1,032) |
| Add: Interest expense | 101 | 101 | 1 | 202 | 2 |
| Add: Income tax provision (benefit) | (1,052) | (2,838) | 112 | (1,980) | (4,985) |
| Add: Depreciation | 3,310 | 3,294 | 3,314 | 12,699 | 13,697 |
| Add: Amortization of completed technology | 1,249 | 1,142 | 1,063 | 4,422 | 4,065 |
| Add: Amortization of customer relationships and acquired intangible assets | 1,648 | 1,606 | 1,439 | 6,170 | 5,694 |
| EBITDA | $ 5,239 | $ 27,600 | $ 11,707 | $ 51,924 | $ 15,226 |
| Quarter Ended | Twelve Months Ended | ||||
| September 30, | June 30, | September 30, | September 30, | September 30, | |
| Dollars in thousands | 2014 | 2014 | 2013 | 2014 | 2013 |
| EBITDA | $ 5,239 | $ 27,600 | $ 11,707 | $ 51,924 | $ 15,226 |
| Adjustments: | |||||
| Less: Income from discontinued operations | — | (27,263) | (4,103) | (30,002) | (4,964) |
| Add: Impairment of completed technology | — | — | 1,910 | 398 | 1,910 |
| Add: Impairment of customer relationships and acquired intangible assets | — | — | 50 | — | 50 |
| Add: Impairment of note receivable | — | 2,621 | — | 2,621 | — |
| Add: Stock-based compensation | 2,138 | 2,258 | 2,103 | 10,914 | 7,608 |
| Add: Restructuring charges | 1,648 | 3,122 | 379 | 6,289 | 6,380 |
| Add: Inventory write-downs related to restructuring programs | — | 310 | — | 310 | — |
| Add: Purchase accounting impact on inventory and contracts acquired | 1,805 | 138 | 134 | 2,295 | 3,041 |
| Add: Merger costs | 79 | 426 | 219 | 686 | 923 |
| Less: Gain on sale of real estate | — | — | (1,025) | — | (1,025) |
| Adjusted EBITDA | $ 10,909 | $ 9,212 | $ 11,374 | $ 45,435 | $ 29,149 |